Pilot Phase III Clinical Trial of JDP-205 IV Injection for Treatment of Acute Urticaria

Summary

This is a multicenter, parallel group, randomized, double-blind pilot Phase III clinical study of JDP-205 (cetirizine) injection, versus diphenhydramine injection, 50 mg/mL (Benadryl or generic equivalent), in approximately 36 patients with acute urticaria requiring treatment in Hospital Emergency Departments, Urgent Care Centers and Allergy Clinics.

Timeline

Start

2013-07

Primary completion

2014-12

Completion

2014-12

Drugs

Indications